PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New discovery could change autoimmune therapy landscape, study suggests

Emory research highlights the therapeutic potential of an enzyme in managing immune-related disorders

New discovery could change autoimmune therapy landscape, study suggests
2024-10-21
(Press-News.org) Myasthenia gravis (MG) is a chronic autoimmune disorder in which antibodies block communication between nerves and muscle, resulting in weakness of the skeletal muscles. It can cause double vision, difficulty swallowing, and, occasionally, serious breathing difficulties, among other symptoms. Many autoimmune diseases such as MG, as well as a range of other human illnesses, result from the inability to regulate activity of IgG antibodies – collectively, these diseases are referred to as IgG-mediated pathologies.

In a paper out this month in Cell, researchers at Emory University have discovered a family of enzymes that work to reduce IgG-mediated pathologies in diseases like MG. The findings, involving mouse models, show that a specific enzyme (an endoglycosidase called CU43) was particularly effective in treating those diseases caused by overactive antibodies.

“Human antibodies, although critically important for mounting an immune response to pathogens and fighting disease, sometimes cause disease themselves – including autoimmune diseases,” says Eric Sundberg, principal investigator on the study and a biochemistry researcher at Emory University’s School of Medicine. “The enzymes we discovered can modify antibodies in such a way that they no longer cause disease.”

A more effective treatment option

The newly discovered enzyme was used to treat a number of different IgG-mediated pathologies in mice and found to be extremely effective. Compared to drugs currently on the market to treat MG, the new enzyme was found to be much more effective in reducing symptoms, and at a much lower dose – 4,000 times less of the enzyme was needed to create the same biological effect. For patients, a more effective, lower dose could mean less side effects and different options for how the drug is administered.

“The potency of this enzyme is quite remarkable when compared to current treatments for autoimmune diseases and thus warrants consideration for further development for the treatment of this important class of diseases,” says Dr. Jeffrey Ravetch, collaborator and co-author on the paper and immunologist at The Rockefeller University.

“We hope to leverage these promising results in mice to move this enzyme rapidly into clinical trials in humans,” says Sundberg, who also chairs the Department of Biochemistry at Emory. “It could potentially be used to treat a wide range of autoimmune diseases and other IgG-mediated pathologies.”

CITATION: Sastre DE, Bournazos S, Du J, Boder EJ, Edgar JE, Azzam T, Sultana N, Huliciak M, Flowers M, Yoza L, et al. (2024). Potent efficacy of an IgG-specific endoglycosidase against IgG-mediated pathologies. Cell. 187(24). 10.1016/j.cell.2024.09.038

FUNDING: Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases grants R01AI149297 (to E.J.S.), R01AI137276 (to S.B.), and U19AI111825 (to J.V.R.) and the National Cancer Institute grant R01CA244327 (to S.B.).

END

[Attachments] See images for this press release:
New discovery could change autoimmune therapy landscape, study suggests New discovery could change autoimmune therapy landscape, study suggests 2 New discovery could change autoimmune therapy landscape, study suggests 3

ELSE PRESS RELEASES FROM THIS DATE:

New attribution studies: Increasing effects of global warming on fire dynamics and public health

2024-10-21
Climate change is increasingly influencing fire behaviour worldwide and intensifying fire smoke, endangering public health from air pollution caused by fires. These are the results of two new climate change impact attribution studies, both published in Nature Climate Change, with involvement of the Potsdam Institute for Climate Impact Research PIK. The first study finds 15.8 percent higher global burned areas over the period 2003 to 2019 due to climate change, intensifying fire activity especially in Australia, South America, Western North America and Siberia. These increasing fire dynamics offset the decrease in burned area ...

Strategies to help patients navigate high prescription drug costs

2024-10-21
About The Study: The current patchwork of strategies to help patients manage high prescription drug costs highlights the structural and policy challenges within the U.S. prescription drug market that impede affordable access for some patients. While these strategies provide tangible solutions for clinicians to help patients access medically appropriate but costly medications, they do not address the root causes of high drug prices. Corresponding Author: To contact the corresponding author, Hussain S. Lalani, MD, MPH, MSc, email hlalani@bwh.harvard.edu. To access the embargoed study: Visit our For The Media website at this ...

City of Hope to present innovative research and treatment options for cancer patients at the 21st International Conference of the Society for Integrative Oncology

2024-10-21
LOS ANGELES — Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, ranked among the nation’s top 5 cancer centers by U.S. News & World Report and a national leader in providing cancer patients with best-in-class, integrated supportive care programs, will present new data on integrative oncology research and clinical trials at the 21st International Conference of the Society for Integrative Oncology taking place Oct. 25 to 27. Integrative oncology is a patient-centered ...

Amsterdam UMC-led researchers develop way to predict epilepsy after rare stroke

2024-10-21
Researchers from 15 countries, led by Amsterdam UMC, have developed a way to predict which patients are at risk of epilepsy after a cerebral venous sinus thrombosis (CVT). CVT is a type of stroke that typically affects women between the ages of 20 and 50. The prediction model is now available worldwide free of charge and research it is based on is published today in JAMA Neurology.  "We hope that as many physicians as possible will use this score to better treat and educate CVT patients across the world," says lead researcher and neurologist at Amsterdam UMC, Jonathan Coutinho.  CVT occurs when a clot blocks the veins ...

National trends in infant mortality in the US after Dobbs

2024-10-21
About The Study: Infant mortality was higher than expected, overall and among those with congenital anomalies, for several months after the Dobbs decision in the U.S. No post-Dobbs months (i.e., no months after June 2022) showed lower than expected infant mortality. These findings are consistent with the increase in infant mortality found in Texas following the state’s abortion ban. Corresponding Author: To contact the corresponding author, Parvati Singh, PhD, email singh.1704@osu.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamapediatrics.2024.4276) Editor’s ...

Stalking ribosomes: How cancer cells pull poker faces

Stalking ribosomes: How cancer cells pull poker faces
2024-10-21
STALKING RIBOSOMES: HOW CANCER CELLS PULL POKER FACES The protein factories of our cells are much more diverse than we thought they were. Scientists from the Netherlands Cancer Institute have now shown that cancer cells can use these so-called ribosomes to boost their invisibility cloak, helping them hide from the immune system. The team publishes their findings in Cell today. “These findings make us change how we think about ribosomes.”  Our immune system is constantly monitoring our body. In order to survive, cancer cells need to evade this ...

At-home brain stimulation for depression is safe and effective, according to research from UTHealth Houston, King’s College London, and University of East London

At-home brain stimulation for depression is safe and effective, according to research from UTHealth Houston, King’s College London, and University of East London
2024-10-21
A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study by researchers at UTHealth Houston; the Institute of Psychiatry, Psychology & Neuroscience at King’s College London; and the University of East London. The research was published in Nature Medicine on Oct. 21, 2024. Transcranial direct current stimulation (tDCS) is a form of noninvasive brain stimulation that applies a weak, direct current of between 0.5 to 2 milliampere to the scalp via two electrodes. It is already commonly used in clinics to treat conditions such as psychosis ...

A 37% drop in overdose deaths from drugs mixed with opioids – fentanyl included

2024-10-21
COLUMBUS, Ohio – Expanded treatment options, increased naloxone distribution and targeted education campaigns likely led to a 37% reduction in overdose deaths from opioids combined with stimulant drugs other than cocaine, according to the results of a large federally funded study. The finding came from a planned study of secondary outcomes of the HEALing (Helping to End Addiction Long-Term) Communities Study (HCS), which tested an intervention encompassing data-driven adoption of evidence-based practices for reducing overdose deaths in Kentucky, Massachusetts, New York and Ohio. Death rates from specific combinations of ...

Research spotlight: Investigating strategies to help clinicians and patients navigate prescription costs

2024-10-21
Hussain S. Lalani, MD, MPH, MSc, of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital, is the lead author of a paper published in JAMA, “Strategies to Help Patients Navigate High Prescription Drug Costs.” How would you summarize your study for a lay audience? Prescription drugs can be expensive for patients, and many clinicians do not know how to respond when costs are too high. We reviewed the benefits and limitations of seven strategies that clinicians can use to help their patients navigate high-prescription drugs. These include co-payment cards, patient assistance ...

Betelgeuse Betelgeuse? Bright star Betelgeuse likely has a ‘Betelbuddy’ stellar companion

Betelgeuse Betelgeuse? Bright star Betelgeuse likely has a ‘Betelbuddy’ stellar companion
2024-10-21
The 10th-brightest star in the night sky, Betelgeuse, may not be on the brink of exploding as a supernova, according to a new study of the star’s brightening and dimming. Instead, recent research shows that the observed pulsing of the starlight is probably caused by an unseen companion star orbiting Betelgeuse. Formally named Alpha Ori B, the “Betelbuddy” (as astrophysicist Jared Goldberg calls it) acts like a snowplow as it orbits Betelgeuse, pushing light-blocking dust out of the way and temporarily making Betelgeuse seem brighter. Goldberg and his colleagues present their simulations of this process in ...

LAST 30 PRESS RELEASES:

Premenstrual symptoms linked to increased risk of cardiovascular disease

Newly discovered remains of ancient river landscapes control ice flow in East Antarctica

Newly discovered interstellar object 'may be oldest comet ever seen'

Animal-inspired AI robot learns to navigate unfamiliar terrain

Underserved youth less likely to visit emergency department for concussion in Ontario, study finds

‘Molecular shield’ placed in the nose may soon treat common hay fever trigger

Beetles under climate stress lay larger male eggs: Wolbachia infection drives adaptive reproduction strategy in response to rising temperature and CO₂

Groundbreaking quantum study puts wave-particle duality to work

Weekly injection could be life changing for Parkinson’s patients

Toxic metals linked to impaired growth in infants in Guatemala

Being consistently physically active in adulthood linked to 30–40% lower risk of death

Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks

Children’s social care involvement common to nearly third of UK mums who died during perinatal period

‘Support, not judgement’: Study explores links between children’s social care involvement and maternal deaths

Ethnic minority and poorer children more likely to die in intensive care

Major progress in fertility preservation after treatment for cancer of the lymphatic system

Fewer complications after additional ultrasound in pregnant women who feel less fetal movement

Environmental impact of common pesticides seriously underestimated

The Milky Way could be teeming with more satellite galaxies than previously thought

New study reveals surprising reproductive secrets of a cricket-hunting parasitoid fly

Media Tip Sheet: Symposia at ESA2025

NSF CAREER Award will power UVA engineer’s research to improve drug purification

Tiny parasitoid flies show how early-life competition shapes adult success

New coating for glass promises energy-saving windows

Green spaces boost children’s cognitive skills and strengthen family well-being

Ancient trees dying faster than expected in Eastern Oregon

Study findings help hone precision of proven CVD risk tool

Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later

Introducing BioEmu: A generative AI Model that enables high-speed and accurate prediction of protein structural ensembles

Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans

[Press-News.org] New discovery could change autoimmune therapy landscape, study suggests
Emory research highlights the therapeutic potential of an enzyme in managing immune-related disorders